Crossref
Use of rituximab and mycophenolate in cortic-dependent nephrotic syndrome in pediatrics
Nefrología Latinoamericana · 08.07.2026 · 23 (2)
DOI: 10.24875/nefro.24000043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nefrología Latinoamericana, online erschienen am 08.07.2026. Verfasst von Miguel Liern und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liern, M., Caturia, A., & Loretti, M. (2026). Use of rituximab and mycophenolate in cortic-dependent nephrotic syndrome in pediatrics. Nefrología Latinoamericana, 23(2). https://doi.org/10.24875/nefro.24000043
Vancouver
Liern M, Caturia A, Loretti M. Use of rituximab and mycophenolate in cortic-dependent nephrotic syndrome in pediatrics. Nefrología Latinoamericana. 2026;23(2). doi:10.24875/nefro.24000043
BibTeX
@article{Liern2026,
author = {Liern, Miguel and Caturia, Ana and Loretti, Maia},
title = {Use of rituximab and mycophenolate in cortic-dependent nephrotic syndrome in pediatrics},
journal = {Nefrología Latinoamericana},
year = {2026},
volume = {23},
number = {2},
doi = {10.24875/nefro.24000043}
}
EUVIMED